Infantile Pure Red Cell Aplasia Secondary to Deficiency of Adenosine Deaminase2 (DADA2) Syndrome—Time to Think Beyond Diamond Blackfan Anemia

IF 2.3 3区 医学 Q2 HEMATOLOGY Pediatric Blood & Cancer Pub Date : 2025-03-17 DOI:10.1002/pbc.31656
Amiya Ranjan Nayak, Jasmita Dass, Himil Parikh, Swapnil Tripathi, Pratyusha Gudapati, Renjith Verghese, Richa Chauhan, Ganesh Kumar Viswanathan, Pradeep Kumar, Rishi Dhawan, Tulika Seth, Manoranjan Mahapatra, Narendra Kumar Bagri, Mukul Aggarwal
{"title":"Infantile Pure Red Cell Aplasia Secondary to Deficiency of Adenosine Deaminase2 (DADA2) Syndrome—Time to Think Beyond Diamond Blackfan Anemia","authors":"Amiya Ranjan Nayak,&nbsp;Jasmita Dass,&nbsp;Himil Parikh,&nbsp;Swapnil Tripathi,&nbsp;Pratyusha Gudapati,&nbsp;Renjith Verghese,&nbsp;Richa Chauhan,&nbsp;Ganesh Kumar Viswanathan,&nbsp;Pradeep Kumar,&nbsp;Rishi Dhawan,&nbsp;Tulika Seth,&nbsp;Manoranjan Mahapatra,&nbsp;Narendra Kumar Bagri,&nbsp;Mukul Aggarwal","doi":"10.1002/pbc.31656","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Deficiency of adenosine deaminase 2 (DADA2) is a rare autosomal recessive disorder characterized by vasculopathy, immunodeficiency, and hematological abnormalities. Its presentation as infantile pure red cell aplasia (PRCA) often mimics Diamond Blackfan anemia (DBA), leading to diagnostic delays and suboptimal management. This study retrospectively analyzed nine cases of DADA2-related PRCA diagnosed over 5 years at a tertiary care hospital. All patients harbored homozygous ADA2 mutations, predominantly p.Ile93Thr, and presented with severe anemia and reticulocytopenia. Misdiagnosed initially as DBA, none responded to steroid therapy. Our findings emphasize the need for comprehensive genetic analysis in PRCA to distinguish DADA2 from DBA for appropriate treatment.</p>\n </div>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":"72 6","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Blood & Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pbc.31656","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Deficiency of adenosine deaminase 2 (DADA2) is a rare autosomal recessive disorder characterized by vasculopathy, immunodeficiency, and hematological abnormalities. Its presentation as infantile pure red cell aplasia (PRCA) often mimics Diamond Blackfan anemia (DBA), leading to diagnostic delays and suboptimal management. This study retrospectively analyzed nine cases of DADA2-related PRCA diagnosed over 5 years at a tertiary care hospital. All patients harbored homozygous ADA2 mutations, predominantly p.Ile93Thr, and presented with severe anemia and reticulocytopenia. Misdiagnosed initially as DBA, none responded to steroid therapy. Our findings emphasize the need for comprehensive genetic analysis in PRCA to distinguish DADA2 from DBA for appropriate treatment.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
继发于腺苷脱氨酶2 (DADA2)缺乏综合征的婴儿纯红细胞发育不全——思考钻石黑扇贫血以外的时间。
腺苷脱氨酶2缺乏症(DADA2)是一种罕见的常染色体隐性遗传病,以血管病变、免疫缺陷和血液系统异常为特征。其表现为婴儿纯红细胞发育不全(PRCA),通常与Diamond Blackfan贫血(DBA)相似,导致诊断延迟和治疗不理想。本研究回顾性分析了一家三级医院5年来诊断的9例与dada2相关的PRCA。所有患者均携带纯合子ADA2突变,主要为p.i ile93thr,并表现为严重贫血和网状红细胞减少症。最初误诊为DBA,没有人对类固醇治疗有反应。我们的研究结果强调需要对PRCA进行全面的遗传分析,以区分DADA2和DBA,以便进行适当的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pediatric Blood & Cancer
Pediatric Blood & Cancer 医学-小儿科
CiteScore
4.90
自引率
9.40%
发文量
546
审稿时长
1.5 months
期刊介绍: Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.
期刊最新文献
Comment on: "Delivering Care Consistent With the Psychosocial Standards: Provider Report From the iSTEPPP Study." Bridging the Gap Between Psychosocial Standards and Real-World Implementation in Pediatric Oncology. Comment on: Targeted Therapy in Pediatric Langerhans Cell Histiocytosis: Describing a Novel Strategy to Minimize Long-Term Exposure While Maintaining Efficacy. A Ball Gown That Fits All. Correction to "Engaging Parents of Children With Sickle Cell Disease in Shared Decision-Making for Hydroxyurea: The ENGAGE-HU Study". Trajectory of Neurocognitive Functioning in Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana-Farber Cancer Institute ALL Consortium Study 16-001. Machine Learning-Based Prediction Model for Delayed Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer: A Prospective Cohort Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1